Matt, Author at European Medical Journal - Page 111 of 212

The Heart of the Matter: A Unique Convergence of Cardiac Neoplasm, Hereditary Nonpolyposis Colorectal Cancer, and Spindle Cell Sarcoma

Cardiac tumours are rare, with their incidence estimated between 0.0017–0.2800%,1 and the vast majority are metastatic lesions…

Obesity and the Effects of Weight Reduction: A Spotlight on Women with Hormone Receptor-Positive Breast Cancer and Heart Disease

There is a connection between increased body mass, or adipose tissue, and higher risk of developing cancer, particularly in hormone-stimulated neoplastic…

Volume Overload Linked to Peritoneal Dialysis Outcomes

Patients undergoing either peritoneal or haemodialysis often present with fluid overload; i.e., retention of excessive amounts of water within the body…

Environmental Factors are Harming the Kidneys of Agricultural Workers

Whilst delineating the genetic factors that influence pathologies can be facilitated through laboratory work or small clinical trials, researchers…

Video-Assisted Thoracoscopic Surgery: Clinical Trial Shows Improvement Over Traditional Surgery

Lung cancer has a relatively poor prognosis, killing nearly 1.8 million people worldwide each year. A common procedure for improving remission rates is…

Using In Utero Gene Editing To Tackle Lethal Lung Disease

Targeting the mid-to-late gestation period of fetal development is an attractive means of averting deadly, and potentially irreversible, pathological…

Unpeeling the Layers of Creativity and Innovation

Creativity and innovation have been described in countless ways; the concepts mean different things to different people, but this fantastic analogy…

Transjugular Intrahepatic Portosystemic Stent-Shunt (TIPSS) for Acute Variceal Bleeding: Has it Come of Age?

Despite the introduction of covered TIPSS, studies have not consistently demonstrated a survival benefit in secondary prevention…

Management of Hepatitis C in People Who Inject Drugs: Some Practical Lessons from the Frontline of the Elimination Battle

One of the critical populations in this battle to achieve elimination is people who inject drugs (PWID), who in the UK represent 85% of the hepatitis C…

Procedural Risk of Bleeding: Does the Management of Thrombocytopenia in Chronic Liver Disease Patients Make a Difference? A Debate

Clinical studies of the TPO-R agonist lusutrombopag included a large proportion of high-risk bleeding patients and therapy with this agent has been shown…